Huadong Medicine with AI leader Insilico improve drug innovation
Aitechpark09 Sep, 2021Technology
Huadong Medicine (SZ.000963) and Insilico Medicine (?Insilico?), an end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the companies have entered into a co-development partnership to accelerate the discovery of breakthrough small-molecule therapeutics by leveraging an innovative approach to oncology.
Related Bookmarks
- EagleAi Platform for business is now available in AWS Marketplace
- Snapsheet Joins NVIDIA to Accelerate the Development of AI Models
- office.com/setup | Enter your Office product key | www.office.com/setup
- Brightflag Awarded U.S. Patent for AI in Legal Operations
- Software Development Company in Lahore � techbridgeconsultancy
- Top 10 Unbelievable Benefits of React native for Cross Platform App Development
- iPhone 13�s satellite connectivity may not be all we imagined
- Awesome Sound System Rental in Dubai at Affordable Price
- Top 5 Required Features to Build Great iOS Apps
- A Comprehensive Guide On Developing A Robust School Bus Management Software
Recent Profiles
Win905 App
Carver Kelleher
Eroica Financial Services
Icon Estimating
Clarke Mccormick
Ascott Parc
Minds Over Matter
F44
Hermann Daugherty
Steenberg Lynn